![Allogene Therapeutics, Inc. [ALLO] posts $332.63M loss as revenue falls 99.37% to $0.2430M](/_next/image?url=http%3A%2F%2F10kinfo-appdata.s3.amazonaws.com%2Fedgar0105%2FCompanyLogos%2FUS%2FALLO.png&w=3840&q=75)
Allogene Therapeutics, Inc. [ALLO] posts $332.63M loss as revenue falls 99.37% to $0.2430M
By USInMinutes
Published - Mar 04, 2023, 12:47 AM ET
Last Updated - Mar 06, 2023, 12:28 PM EST
| Net Sales: | $0.2430M |
Allogene Therapeutics, Inc. [ALLO] posted a loss of $332.63M, marking a fall of 29.43% for this year.
Revenue fell to $0.2430M this year compared to $38.49M in the previous year.
According to the latest annual report the company has filed with the SEC, current earnings were $-332.63M, down 29.43% from $-257.00M.
The company’s net sales for the period were $0.2430M, down 99.37%. Net sales in the previous year were $38.49M.
